We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GCL:NASDAQGCL Global Holdings Ltd Analysis

Data as of 2026-06-11 - not real-time

$0.43

Latest Price

8/10Risk

Risk Level: High

Executive Summary

GCL is trading deep in a bear market at $0.431, barely above the calculated support of $0.411 and well under its 20‑day and 50‑day SMAs (~$0.526 and $0.532). The RSI of 39.7 hints at oversold conditions, yet the MACD remains bearish and volume is slipping, underscoring continued downward pressure. Technical metrics combine with a soaring 30‑day volatility of 180% and a beta above 2, flagging extreme price swings.
Fundamentally, the company shows a mixed picture: revenue surged 94% year‑over‑year, but gross margins sit at just 13% and operating margins are negative. Cash flow is deeply in the red (operating cash flow ~‑$13 M, free cash flow ~‑$24 M) while debt outpaces cash (debt‑to‑equity ≈ 162%). The trailing PE of 43 is far above the industry average of 16.9, suggesting the stock is overvalued relative to earnings. No dividend is paid, and the balance sheet is strained. Recent news of the “Realm of Ink” launch and a strategic investment from ADATA Technology provide potential catalysts, but they must first overcome the heavy financial headwinds.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price hovering just above a firm support level
  • Bearish technical indicators (MACD, SMAs, decreasing volume)
  • Extreme short‑term volatility and high beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from new game launch and ADATA investment
  • Still negative cash flow and high leverage
  • Valuation remains stretched despite revenue growth

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Revenue growth trajectory could eventually improve profitability
  • Structural risks from debt load and cash‑flow deficits
  • Industry dynamics and regulatory environment remain uncertain

Key Metrics & Analysis

Financial Health

Revenue Growth93.90%
Profit Margin0.53%
P/E Ratio43.1
ROE1.17%
ROA-1.30%
Debt/Equity161.65
P/B Ratio1.6
Op. Cash Flow$-12951616
Free Cash Flow$-24467724
Industry P/E16.9

Technical Analysis

TrendBearish
RSI39.7
Support$0.41
Resistance$0.96
MA 20$0.53
MA 50$0.53
MA 200$1.28
MACDBearish
VolumeDecreasing
Fear & Greed Index84.64

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.15
Volatility180.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.